Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy

Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy

Abstract Background Prostate cancer (PCa) is the second leading cause of cancer-related deaths among men worldwide. Immunotherapy is an emerging treatment modality for cancers that harnesses the immune system’s ability to eliminate tumor cells. In particular, dendritic cell (DC) vaccines, have demon...

Full description

Bibliographic Details
Main Authors: Parisa Bakhshi, Maryam Nourizadeh, Laleh Sharifi, Mohammad M. Farajollahi, Monireh Mohsenzadegan
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Cancer Cell International
Subjects:
Dendritic cell vaccine
Immunotherapy
MAGE-A2
Long peptide
Prostate cancer
Online Access:https://doi.org/10.1186/s12935-023-03108-0

Internet

https://doi.org/10.1186/s12935-023-03108-0

Similar Items